AHA Scientific Sessions 2023 Poster: Lorundrostat for Treatment of Obesity-Related, Aldosterone-Dependent Hypertension
– An Endotype-Specific, Targeted Approach to the Treatment of Uncontrolled Hypertension
– An Endotype-Specific, Targeted Approach to the Treatment of Uncontrolled Hypertension